Despite failed primary endpoints, AzaSite shows promise for treating blepharitis in clinical program
Links shared publicly online about this topic.
- 1,313total visits
Despite failed primary endpoints, AzaSite shows promise for treating blepharitis in clinical program
DURHAM, N.C. — AzaSite was well-tolerated and statistically significantly improved the signs and symptoms of blepharitis in a phase 2 clinical pr
View full resource at osnsupersite.com
Tags: Eyelid Disorder
Most Recently Shared on March 16, 2010 at 6:05 am By:
Despite failed primary endpoints, AzaSite shows promise for treating blepharitis in clinical program: http://ow.ly/1ldft
Advertisement
